Related Experiment Video
Updated: May 29, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
Back pain: a real target for spinal cord stimulation?
Philippe Rigoard1, Alexandre Delmotte, Samuel D'Houtaud
1Department of Neurosurgery, Poitiers University School of Medicine, Poitiers, France. p.rigoard@chu-poitiers.fr
Neurosurgery
|September 23, 2011
Summary
New spinal cord stimulation (SCS) leads effectively cover back pain areas, offering significant relief for failed back surgery syndrome patients. This advancement expands neurostimulation possibilities for chronic back pain management.
Area of Science:
- Neurology
- Pain Management
- Biomedical Engineering
Background:
- Failed back surgery syndrome (FBSS) is a primary cause of chronic back pain, posing a significant public health challenge.
- Current spinal cord stimulation (SCS) systems face technological limitations hindering their effectiveness for back pain.
- New multi-column leads offer advanced stimulation capabilities for the spinal cord.
Purpose of the Study:
- To evaluate the efficacy of multi-column tripolar leads in achieving back pain coverage.
- To assess the capacity of these leads in providing paresthesia in the back territory for FBSS patients.
Main Methods:
- Eleven FBSS patients were implanted with a 16-contact SCS lead (Specify 5-6-5).
- Extensive stimulation testing explored 43 configurations for bilateral back and leg paresthesia.
- Systematic assessment focused on achieving dorsal paresthesia coverage.
Main Results:
- Multi-column tripolar leads successfully generated paresthesia in both back and leg regions for 81.8% of patients.
- Success rates for multi-column patterns were superior to longitudinal configurations for back paresthesia.
- Significant pain reduction was observed at 6 months post-implantation (global, leg, and back pain).
Conclusions:
- Multi-column leads demonstrate reliability in providing back pain coverage and improving pain relief outcomes.
- These findings may prompt a reevaluation of SCS indications for chronic back pain.
- Neurostimulation for intractable back pain syndromes appears increasingly feasible.
